U.S. Department of Defense Awards Rafa Laboratories Production follow-on Agreement of over $45 million

Rafa recently secured a 45 million $US deal with the US Department of Defense for its midazolam autoinjector which was approved by the US-FDA in 2022.

Rafa is very proud of this achievement and hopes to bring this life saving product to people in need all over the world.

We would like to thank the JPEO-CBRND for their partnership and support.  Read more >>